AstraZeneca's push into CAR-T therapies for cancer has continued with an agreement to take full control of C-CAR031, an anti-GPC3 therapy for solid tumours, from AbelZeta. In the latest development, ...

Building a smart ecosystem in your home is more accessible than ever, with a range of products that automate and regulate the ...